Stimuli-Responsive CuFeTe<sub>2</sub> Nanosheets for Amplified Cuproptosis/Ferroptosis in Triple-Negative Breast Cancer Therapy.
Ontology highlight
ABSTRACT: Triple-negative breast cancer (TNBC) exhibits high copper and iron uptake, making cuproptosis and ferroptosis promising therapeutic strategies. However, their efficacy is limited by TNBC's intrinsic antioxidant defences. Herein, CuFeTe2 nanosheets (CFT) with internal tumour microenvironment (TME) responsiveness and external NIR-II mild photothermal enhancement is developed to synergistically overcome this antioxidant defences, amplifying both pathways for improved TNBC therapy. In the acidic TME, CFT releases Fe2+ and Cu2+. Cu2+ reacted with glutathione (GSH) to generate Cu+, inhibiting glutathione peroxidase 4 (GPX4), amplifying lipid peroxidation (LPO), and triggering ferroptosis. Cu⁺ also induce dihydrolipoamide S-acetyltransferase
SUBMITTER: Liu M
PROVIDER: S-EPMC12806277 | biostudies-literature | 2026 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA